AMP's 4th Annual Molecular Pathology Economics Summit
August 16th, 2024
Omni Shoreham Hotel, Washington D.C.

AMP’s Molecular Pathology Economics Summit will be a highly interactive one-day event that will:

  • Identify barriers to appropriate reimbursement for molecular pathology procedures;
  • Examine the impact of these barriers on various stakeholders and patient access to care; and
  • Propose potential solutions and/or novel approaches to overcoming barriers to implement shared policy goals from participating stakeholders in oncology, infectious diseases, and inherited conditions.

Registration Information


Registration pricing is for a single individual. Please select your registration type based on your current organization. To register for this event 1.) click Register (above) 2.) either login using your AMP credentials or scroll down to create a new account.

IMPORTANT: Participation is limited and we encourage you to register and reserve your space as soon as possible. We anticipate that this event will sell-out. 

Registration Type  Advanced Registration
(Until July 14th)
(July 14th Onward)
Associations & Patient Advocacy Groups* First Attendee from your organization is FREE First Attendee from your organization is FREE
Non-Profit Organizations $375 USD $400 USD
For-Profit Organizations** $950 USD $1,150 USD

*Association and Patient Advocacy Groups - The first attendee from any association or patient advocacy group will receive free registration. Additional registrants from any association or patient advocacy group must register at the Non-Profit registration rate. To access your free registration (or to confirm if you are the first registrant), please contact the AMP Public Policy and Advocacy Department at:

**Corporate Advisory Council members may receive free registration as a benefit of AMP Partnership. Please contact Laurie Menser ( regarding these registrations.

Cancellation Policy: Cancellations received by written notification to through July 1st will receive a refund (less a $100 processing fee). No refunds after July 1st.

Pay by Check: To pay by check please contact us at

Registration Instructions:

1.) Click the Register Now button above

2.) Login using your AMP credentials or conduct a password reset

3.) Don't have a AMP credentials? Click "New User? Click Here" to create an account

4.) Once logged in, click "Events" at the top of the page

5.) Select the Molecular Pathology Economics Summit and proceed.

If you have any questions during the registration process contact us at

2023 Summary of Themes

  On September 13th, 2023, AMP hosted the third Economics Summit with the following objectives:

  • Identify and analyze the aspects of coding, pricing and reimbursement that create barriers to patient access.
  • Discuss potential solutions to those barriers and provide practical, interdisciplinary action items to implement across the sector.

Access the document below:


AMP was pleased to facilitate this event and sought to have broad stakeholder input, which consisted of 60 individuals representing diagnostic manufacturers, pharmaceutical companies, trade associations, professional organizations, clinical laboratories, and patient advocacy groups. The Summit was divided into three sessions. The first focused on various stakeholder perspectives with representation from clinical laboratories, pharmaceutical companies, patient advocacy organizations, and diagnostic manufacturers and their respective approaches to the unique challenges associated with molecular diagnostic coding, coverage, and reimbursement. These interactive, candid conversations explored barriers and potential solutions to patient access.  AMP also held breakout sessions to identify shared policy priorities which allowed stakeholders to determine practical and applicable solutions. Each of the four groups provided several proposed action items for stakeholders to implement in 2024. The third session, led by AMP, facilitated discussions on the future of molecular pathology including artificial intelligence. 



Clifford Goodman, PhD, has 35 years of experience in such areas as health technology assessment, evidence-based health care, clinical practice guidelines, health economics, and studies pertaining to health care innovation, regulation, and payment.  He directs studies and projects for an international range of government agencies; pharmaceutical, biotechnology, and medical device companies; health care provider institutions; and professional, industry, and patient advocacy groups.  His recent work has involved such areas as chronic disease, infectious disease, cancer, rare diseases, diagnostic testing, gene therapy, pharmacogenomics, personalized medicine, biosimilars, value frameworks, value-based contracting, social determinants of health, and applications of real-world data.  Dr. Goodman is an internationally recognized health policy issues moderator and facilitator of expert panels, advisory boards, workshops, and focus groups. 

Dr. Goodman served as chair of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC, 2009-12) for the Centers for Medicare and Medicaid Services (CMS).  He served as president of the professional society, Health Technology Assessment international (HTAi, 2011-13), and is a Fellow of the American Institute for Medical and Biological Engineering.  In 2022, he received the David Banta Distinguished Career Award in Health Technology Assessment from HTAi.  He earned a PhD from The Wharton School of the University of Pennsylvania, a Master of Science from The Georgia Institute of Technology, and a Bachelor of Arts from Cornell University. 

After 27 years, including as Senior Vice President, Dr. Goodman recently retired from The Lewin Group and is an independent consultant in health care technology and policy.

Notify Me

If you would like to be notified as more information becomes available, please complete this form.

Summit Planning Committee

AMP Economic Affairs Committee Chair
Jay Patel, MD
ARUP Laboratories

AMP Economic Affairs Committee Economics Summit Planning Chair
Samuel K. Caughron, MD
MAWD Pathology Group, P.A.

AMP Economic Affairs Committee Vice Chair: Coverage Decisions Infectious Disease
Erin Graf, BS, PhD
Mayo Clinic

AMP Economic Affairs Committee Vice Chair: Coverage Decisions Genetics and Oncology
Eric Vail, MS, MD
Cedars-Sinai Medical Center

AMP Economic Affairs Committee Vice Chair: New Codes and Pricing
Victoria M. Pratt, PhD, FACMG
Agena Bioscience

AMP Economic Affairs Committee Member
Jeff Gagan, MD/PhD
National Cancer Institute

AMP Economic Affairs Committee Member
Lloyd Hutchinson, PhD
UMass Memorial Medical Center

AMP Economic Affairs Committee Member
Rina Kansal, MD
Blood Center of Wisconsin

AMP Economic Affairs Committee Member
Ester Stein, BS, MBA

AMP Economic Affairs Committee Member
Heather E. Williams, MS, PhD
Cache DNA

Government Relations Consultants: Innovative Policy Solutions
Jennifer Leib, ScM, CGC

Megan Anderson Brooks, PhD

Lindsey Trischler, MPAP


Hotel & Travel Information

The 2024 AMP Molecular Pathology Economics Summit will be held at the Omni Shoreham Hotel, Washington DC.  AMP has negotiated with the host venue to provide attendees with the discounted room rate of $169.00 (USD) per night (+applicable taxes and fees). The Hotel Reservation Deadline July 12, 2024.

Book Your Room
Travel & Airport Information


For more information on becoming an Industry Partner for this event please contact, Laurie Menser.

Corporate Partners